Gregory Bailey has bought stock on 11 days since May 2017

Gregory H. Bailey, M.D. is an independent director at Biohaven Ltd. (BHVN), serving since September 2022 after previously directing the former parent company since January 2014.( Age 69, Dr. Bailey holds an M.D. from the University of Western Ontario and practiced emergency medicine for ten years before transitioning to biotech finance and entrepreneurship.(

Dr. Bailey is CEO and co-founder of Juvenescence Limited, a private life sciences company focused on longevity, and Executive Chairman there as well.( His career highlights include founding Palantir Group Inc., a biotech merchant bank, co-founding SalvaRx Group Plc, Portage Biotech Inc. (where he serves as Chairman), and Medivation Inc. (director 2005–2012, acquired by Pfizer).( He currently holds directorships at Manx Financial Group, Serina Therapeutics, and Portage Pharmaceuticals, with significant BHVN equity ownership aligning his interests.( Dr. Bailey chairs Biohaven's Nominating & Corporate Governance Committee and serves on the Audit Committee.(

Written by Perplexity from public sources.